Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-05-22 15:12:36 UTC |
---|
Updated at | 2021-10-07 20:40:57 UTC |
---|
NP-MRD ID | NP0000261 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | N-Methylnicotinamide |
---|
Description | N-methylnicotinamide (NMA), also known as Nicotinyl methylamide or N-methylniacinamide, belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. N-methylnicotinamide is also classified as a pyridinecarboxamide, which consists a pyridine group attached to a carboxamide moiety. More specifically, N-methylnicotinamide is nicotinamide in which one of the amide hydrogens in the carboxamide group is substituted by a methyl group. Note that N-methylnicotinamide is structurally and functionally different than N(1)-methylnicotinamide (also called 1-methylnicotinamide). Unfortunately, there is extensive confusion and mis-labeling of N-methylnicotinamide and N(1)-methylnicotinamide in the scientific literature. N-methylnicotinamide is a metabolite of niacin (vitamin B3 or nicotinamide) and is commonly found in human urine. Low levels of urinary excretion of N-methylnicotinamide can indicate a niacin deficiency. In patients with liver cirrhosis, nicotinamide methylation is increased which can lead to a rise in urinary N-methylnicotinamide (PMID: 11316167 ). Increased methylation of nicotinamide in cirrhosis patients might play a protective role against the toxic effects of intracellular accumulation of nicotinamide deriving from the catabolic state of cirrhosis (PMID: 11316167 ). N-methylnicotinamide is known to inhibit choline transport and reduce choline clearance out of the brain. N-methylnicotinamide has been shown to improve endothelial dysfunction and to attenuate atherogenesis via the modulation of asymmetric dimethylarginine (ADMA) and dimethylarginine dimethylaminohydrolase (PMID: 26887666 ). N-methylnicotinamide significantly increases nitric oxide/cyclic guanosinemonophosphate levels and decreases asymmetric dimethylarginine (ADMA) concentrations by induction of dimethylarginine dimethylaminohydrolase (DDAH) both in aorta and endothelial cells. N-methylnicotinamide has also been identified as a microbial metabolite. |
---|
Structure | InChI=1S/C7H8N2O/c1-8-7(10)6-3-2-4-9-5-6/h2-5H,1H3,(H,8,10) |
---|
Synonyms | Value | Source |
---|
3-(Methylcarbamoyl)pyridine | ChEBI | 3-(N-Methylcarbamoyl)pyridine | ChEBI | N-Methyl nicotineamide | ChEBI | N-Methyl-3-pyridinecarboxamide | ChEBI | N-Methylpyridine-3-carboxamide | ChEBI | Nicotinic acid methylamide | ChEBI | Nicotinate methylamide | Generator | N-METHYL-nicotinamide | HMDB | N-Methylnicotinamide monohydrochloride | HMDB | N -Methyl nicotineamide | HMDB |
|
---|
Chemical Formula | C7H8N2O |
---|
Average Mass | 136.1512 Da |
---|
Monoisotopic Mass | 136.06366 Da |
---|
IUPAC Name | N-methylpyridine-3-carboxamide |
---|
Traditional Name | N'methylnicotinamide |
---|
CAS Registry Number | 114-33-0 |
---|
SMILES | CNC(=O)C1=CN=CC=C1 |
---|
InChI Identifier | InChI=1S/C7H8N2O/c1-8-7(10)6-3-2-4-9-5-6/h2-5H,1H3,(H,8,10) |
---|
InChI Key | ZYVXHFWBYUDDBM-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, simulated) | V.dorna83 | | | 2021-09-05 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, simulated) | Varshavi.d26 | | | 2021-08-05 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as nicotinamides. These are heterocyclic aromatic compounds containing a pyridine ring substituted at position 3 by a carboxamide group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pyridinecarboxylic acids and derivatives |
---|
Direct Parent | Nicotinamides |
---|
Alternative Parents | |
---|
Substituents | - Nicotinamide
- Heteroaromatic compound
- Secondary carboxylic acid amide
- Carboxamide group
- Azacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 103.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 0.00 | Hansch CH, Leo A and Hoekman DH. "Exploring QSAR: Hydrophobic, Electronic, and Steric Constraints. Volume 1" ACS Publications (1995). |
|
---|
Predicted Properties | |
---|
General References | - Pumpo R, Sarnelli G, Spinella A, Budillon G, Cuomo R: The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production. Am J Gastroenterol. 2001 Apr;96(4):1183-7. [PubMed:11316167 ]
- Aleinik SI, Kodentsiva VM, Mitin IE, Sokol'nikov AA, Vrzhesinskaia OA, Isaeva VA, Terekhina TA, Stroganova AS, Erzhen K, Tsibul'skaia OA, et al.: [Effects of the use of a multivitamin preparation "Pikovit" (KRKA, Yugoslavia) on providing nursery children with vitamins]. Vopr Pitan. 1992 May-Jun;(3):14-9. [PubMed:1387494 ]
- Cuomo R, Pumpo R, Sarnelli G, Capuano G, Budillon G: Nicotinamide methylation and hepatic energy reserve: a study by liver perfusion in vitro. J Hepatol. 1995 Oct;23(4):465-70. [PubMed:8655965 ]
- Pitche PT: [Pellagra]. Sante. 2005 Jul-Sep;15(3):205-8. [PubMed:16207585 ]
- Jiang N, Wang M, Song J, Liu Y, Chen H, Mu D, Xia M: N-methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice. Mol Nutr Food Res. 2016 Jul;60(7):1625-36. doi: 10.1002/mnfr.201501019. Epub 2016 May 4. [PubMed:26887666 ]
|
---|